Statistics
Publications
14
Citations
1K
H-Index
12
Active since
1986
Mac Johnson is an author at Vertex Pharmaceuticals (United States) specializing in medicine, oncology, and prostate cancer.
Publications per year
1986–2017
14
14
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
Amy B. Hall, Dave Newsome, Yuxin Wang et al. · Oncotarget · 2014 · 195 citations · Full text
Medicine, Oncology, Pharmacology +16
Michael Zinda, Mac Johnson, Joshua Paul et al. · PubMed · 2001 · 150 citations
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model
Ian Tagge, Audrey O’Connor, Priya Chaudhary et al. · PLoS ONE · 2016 · 78 citations · Full text
1–5 of 14